|
|
|
|
|
by scotty79
2641 days ago
|
|
> Should the cost of CPUs be separate from the cost of CPU research? Maybe not now when researching CPUs is fairly easy. But a century in the future? When faster CPUs will be very hard to invent but essential to human survival? Maybe. Business is great at researching processes of manufacturing. Not so good when it comes to researching actually new stuff. > As long as the cost of drugs were reasonable, we wouldn't need to have these conversations. But they must become unreasonable at some point if they cost as much as the incentive for research for companies. Companies are most risk-averse entities in existence. It's not unexpected that they need unreasonably high incentives to take up the risk of doing research. |
|
I'd say we're already at the point that they are essential to our survival, at least for societies as they currently exist. CPUs are also hard to invent, and hard to progress already, requiring hundreds of millions of dollars for each new iteration.
> Business is great at researching processes of manufacturing. Not so good when it comes to researching actually new stuff.
I don't believe it. Most of the things we currently use were invented by businesses, or by someone who then started a business to sell it.
> But they must become unreasonable at some point if they cost as much as the incentive for research for companies.
Again, you're assuming the conclusion. Maybe this is the case in some circumstances, but it's a assuming a lot to claim this is the case for all companies and all drugs.
And if the cost is really this high, then incentivizing more creative approaches to treatment might just be better anyway. It shows a lack of imagination if we can only use a hammer when faced with a health problem.